Papillary carcinoma of the thyroid is the most common cancer of the thyroid gland.
See also: Thyroid cancer
Alternative NamesPapillary carcinoma of the thyroid
Causes, incidence, and risk factorsAbout 80% of all thyroid cancers diagnosed in the United States are papillary carcinoma type. It is more common in women than in men. It may occur in childhood, but is most often seen in adults around the age of 45.
The cause of this cancer is unknown. A genetic defect may be involved.
Radiation increases the risk of developing thyroid cancer. Exposure may occur from:
Radiation given through a vein (through an IV) during medical tests and treatments does not increase the risk of developing thyroid cancer.
SymptomsThyroid cancer usually begins as a small lump (nodule) in the thyroid gland, which is located at the center part of the front of the neck.
While some small lumps may be cancer, most thyroid nodules are harmless and are not cancerous.
Most of the time, there are no other symptoms.
Signs and testsIf you have a lump on your thyroid, your doctor will order blood tests and possibly an ultrasound of the thyroid gland.
If the ultrasound shows that the lump is bigger than 1.0 centimeter, a special biopsy called a fine needle aspiration(FNA) will be performed. This test helps determines if the lump is cancerous.
Thyroid function tests are usually normal in patients with thyroid cancer.
TreatmentThere are three types of thyroid cancer treatment:
Surgery is done to remove as much of the cancer as possible. The bigger the lump, the more of the thyroid gland must be removed. Frequently, the entire gland is taken out.
After the surgery, most patients should receive radioactive iodine, which is usually taken by mouth. This substance kills any remaining thyroid tissue. It also helps make medical images more clear, so doctors can see if there is any additional cancer.
If surgery is not an option, external radiation therapy can be useful.
After surgery or radioactive iodine, the patient will need to take medication called levothyroxine sodium for the rest of their life. This replaces the hormone that the thyroid would normally make.
Most patients who had thyroid cancer need to a blood test every 6 - 12 months to check thyroid levels. Other follow-up tests that may done after treatment for thyroid cancer include:
The survival rate for papillary thyroid cancer is excellent. More than 95% of adults with such cancer survive at least 10 years. The prognosis is better for patients younger than 40 and for those with smaller tumors.
The following factors may decrease the survival rate:
Complications include:
Call your health care provider if you have a lump in your neck.
ReferencesLadenson P, Kim M. Thyroid. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 244.
National Comprehensive Cancer Network. NCCN Guidelines in Oncology 2010: Thyroid Cancer. Version 1.2010.
Papillary carcinoma of thyroid (excellent prognosis)
The scientific name for bladder cancer is "urothelial carcinoma," formerly known as "transitional cell carcinoma." Urothelial carcinoma is the most common type of bladder cancer, accounting for the majority of cases. It originates in the urothelial cells, which line the inside of the bladder and the urinary tract. Other less common types of bladder cancer include squamous cell carcinoma, adenocarcinoma, and small cell carcinoma, but urothelial carcinoma is the most prevalent.
Papillary thyroid cancer is considered the most common form of thyroid cancer. According to ThyroidAwareness.com, papillary thyroid cancer is most commonly diagnosed in women 30-40 years old and it most frequently spreads to the neck lymph nodes.
no
The term "medullary" in the context of thyroid cancer refers to a specific type of thyroid cancer that originates from the parafollicular C cells, which produce calcitonin. This connotation often implies a more aggressive nature compared to other types of thyroid cancer, such as papillary or follicular thyroid carcinoma. Medullary thyroid carcinoma can also be associated with genetic syndromes, highlighting its relevance in hereditary cancer risk assessments. Overall, the term conveys a distinct and clinically significant subtype within thyroid malignancies.
yes.
Papillary, follicular, medullary and anaplastic
Anaplastic thyroid cancer usually arises from a site of preexisting papillary thyroid cancer or follicular thyroid cancer. The transformed cells that grow to form this type of cancer divide rapidly to form disorganized masses. Anaplastic thyroid cancer tends to grow very rapidly, replacing the normal tissue of the thyroid gland and spreading to invade and metastasize to other structures in the neck. It does not respond well to treatment. Surgery and external beam radiation therapy may be used to treat cases where aggressive growth of cancer has significantly impaired swallowing or breathing. On the whole, anaplastic thyroid cancer has a very poor prognosis.
The papillary type of renal cell carcinoma tends to spread to areas near the site of origin, but it is possible.
is it okay to take oral contraceptive after undergoing surgery (breast incision, frozen section) wherein i was diagnosed with papillary carcinoma ductal in-situ?
Thyroid cancer is generally associated with very high survival rates. The prognosis for thyroid cancer is often favorable, with the majority of patients surviving the disease. Survival rates can vary depending on the specific type and stage of thyroid cancer. Here are some general survival rate statistics: Papillary Thyroid Cancer: Papillary thyroid cancer, the most common type, has a high survival rate. The 5-year relative survival rate for localized papillary thyroid cancer is approximately 99%, meaning that almost all patients with localized disease are alive 5 years after diagnosis. Even for regional (spread to nearby lymph nodes) or distant (metastatic) disease, the 5-year survival rate remains relatively high at around 93%. Follicular Thyroid Cancer: Follicular thyroid cancer also has favorable survival rates. The 5-year relative survival rate for localized disease is approximately 97%. For regional disease, it's about 86%, and for distant disease, it's around 67%. Medullary Thyroid Cancer: Medullary thyroid cancer has slightly lower survival rates compared to papillary and follicular types. For localized disease, the 5-year relative survival rate is around 98%. For regional disease, it's about 89%, and for distant disease, it drops to approximately 41%. Anaplastic Thyroid Cancer: Anaplastic thyroid cancer is the most aggressive form of thyroid cancer, and survival rates are much lower. The 5-year relative survival rate for this type is generally less than 10%, and many cases are fatal.
Located in the front of your lower neck, the thyroid is the largest endocrine gland in the human body. It is responsible for how the body uses energy by producing proteins and determining how sensitive the body is to hormones. Thyroid cancer is a cancer that starts in the thyroid gland but can spread to other parts of the body. Symptoms of thyroid cancer can include neck swelling, persistent cough, swelling in the neck, enlargement of the thyroid gland, and problems swallowing. There are four types of thyroid cancer: papillary, anaplastic, medullary, and follicular. The most common type of thyroid cancer is papillary carcinoma and usually affects women under 45. It is the least dangerous type of cancer as it spreads more slowly, which enables earlier detection. Most people with this type of thyroid cancer are cured and can expect to have a normal life span. The rarest form, anaplastic carcinoma, also is the most dangerous type of thyroid cancer. It spreads rapidly, usually ruling out a quick surgical removal, and does not respond well to radiation therapy. No matter how aggressive the treatment, this type of thyroid cancer is usually deadly. Medullary carcinoma has a genetic basis, as it tends to appear among families. This cancer occurs in those non-thyroid cells generally present in the thyroid. The treatment outcomes vary greatly, with younger women tending to experience better outcomes than most patients. Accounting for a tenth of all thyroid cancers, follicular carcinomas often are fast growing but highly treatable. Most patients with this type of thyroid cancer can expect to be fully cured. The most common form of treatment is surgery, with the entire gland being removed. It is very common for lymph nodes to be removed at this time as well. Radiation therapy often is used, either through x-ray radiation or ingesting radioactive iodine. Chemotherapy can be used if the cancer has spread to other parts of the body, but this is rarely effective for any but a small number of patients.